Magnus Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.92M | Buy |
6,605
+89
| +1% | +$90.9K | 0.56% | 43 |
|
|
2026
Q1 | $5.99M | Sell |
6,516
-183
| -3% | -$186K | 0.49% | 49 |
|
|
2025
Q4 | $7.2M | Buy |
6,699
+70
| +1% | +$66.9K | 0.55% | 44 |
|
|
2025
Q3 | $5.06M | Buy |
6,629
+244
| +4% | +$182K | 0.4% | 58 |
|
|
2025
Q2 | $4.98M | Buy |
6,385
+254
| +4% | +$197K | 0.44% | 51 |
|
|
2025
Q1 | $5.06M | Buy |
6,131
+103
| +2% | +$85.7K | 0.49% | 45 |
|
|
2024
Q4 | $4.65M | Buy |
6,028
+214
| +4% | +$177K | 0.45% | 51 |
|
|
2024
Q3 | $5.15M | Sell |
5,814
-267
| -4% | -$240K | 0.52% | 44 |
|
|
2024
Q2 | $5.51M | Buy |
6,081
+525
| +9% | +$420K | 0.62% | 34 |
|
|
2024
Q1 | $4.32M | Buy |
5,556
+138
| +3% | +$98.2K | 0.51% | 40 |
|
|
2023
Q4 | $3.16M | Buy |
5,418
+163
| +3% | +$95.1K | 0.41% | 48 |
|
|
2023
Q3 | $2.82M | Buy |
5,255
+52
| +1% | +$26.8K | 0.41% | 45 |
|
|
2023
Q2 | $2.44M | Buy |
5,203
+42
| +0.8% | +$17.6K | 0.35% | 50 |
|
|
2023
Q1 | $1.77M | Buy |
5,161
+299
| +6% | +$101K | 0.27% | 69 |
|
|
2022
Q4 | $1.78M | Buy |
4,862
+105
| +2% | +$37.2K | 0.29% | 67 |
|
|
2022
Q3 | $1.54M | Buy |
4,757
+775
| +19% | +$246K | 0.29% | 67 |
|
|
2022
Q2 | $1.29M | Buy |
3,982
+475
| +14% | +$143K | 0.24% | 78 |
|
|
2022
Q1 | $1M | Buy |
3,507
+662
| +23% | +$170K | 0.17% | 103 |
|
|
2021
Q4 | $786K | Buy |
2,845
+405
| +17% | +$103K | 0.15% | 104 |
|
|
2021
Q3 | $564K | Buy |
2,440
+7
| +0.3% | +$1.73K | 0.12% | 118 |
|
|
2021
Q2 | $558K | Buy |
2,433
+665
| +38% | +$134K | 0.12% | 112 |
|
|
2021
Q1 | $330K | Sell |
1,768
-2,037
| -54% | -$398K | 0.08% | 164 |
|
|
2020
Q4 | $643K | Buy |
3,805
+89
| +2% | +$13.3K | 0.06% | 114 |
|
|
2020
Q3 | $550K | Sell |
3,716
-1,307
| -26% | -$202K | 0.06% | 119 |
|
|
2020
Q2 | $825K | Buy |
5,023
+6
| +0.1% | +$921 | 0.09% | 88 |
|
|
2020
Q1 | $696K | Buy |
5,017
+101
| +2% | +$13.9K | 0.09% | 106 |
|
|
2019
Q4 | $646K | Buy |
4,916
+111
| +2% | +$12.9K | 0.09% | 101 |
|
|
2019
Q3 | $537K | Buy |
4,805
+41
| +0.9% | +$4.57K | 0.1% | 105 |
|
|
2019
Q2 | $528K | Buy |
4,764
+7
| +0.1% | +$824 | 0.1% | 109 |
|
|
2019
Q1 | $617K | Buy |
4,757
+7
| +0.1% | +$851 | 0.13% | 83 |
|
|
2018
Q4 | $550K | Buy |
+4,750
| New | +$531K | 0.15% | 73 |
|
Other funds holding LLY
Magnus Financial Group's LLY Position: Q2 2026 in Review
Magnus Financial Group increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $90.9K and bringing the position to 6,605 shares worth $7.92M. The position accounts for 0.56% of the portfolio, ranked #43.
Magnus Financial Group first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Magnus Financial Group held 6,605 shares of Eli Lilly worth $7.92M as of Q2 2026.
- Magnus Financial Group bought 89 Eli Lilly shares in Q2 2026, an estimated $90.9K.
- Eli Lilly made up 0.56% of Magnus Financial Group's portfolio in Q2 2026, its #43 holding.
- Magnus Financial Group first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.